What is NDC 62484-0020?

62484-0020 is the product NDC for Purixan, Mercaptopurine 20 mg/mL suspension, listed with the FDA by Nova Laboratories, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.

Nova Laboratories, Ltd, NDC labeler code 62484. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Purixan?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Purixan NDC 62484-0020 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62484-0020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62484-0020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62484-0020-2	6248400200262484002002	1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1)Marketed from Apr 28, 2014

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Purixan
Generic name (nonproprietary): purixan
Active ingredients: Mercaptopurine — 20 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Nova Laboratories, LtdNDC labeler code 62484
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 205919
Marketing start: Apr 28, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Nucleic Acid Synthesis Inhibitors (Mechanism)
Identifiers: Product ID 62484-0020_b8e1aeb8-2f0a-41b0-84d7-2c33a407926bSPL ID b8e1aeb8-2f0a-41b0-84d7-2c33a407926bSPL set ID 9fd27952-7787-47d9-b6cf-7af2dc38217bRxCUI 1536484, 1536490UNII E7WED276I5UPC 0362484002018
Pharmacologic class: Nucleoside Metabolic Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462484002002 followed by a unit qualifier and the quantity

Package 62484-0020-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 20, 2026.

Indications (excerpt from the label)

PURIXAN is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.( 1.1 ) 1.1 Acute Lymphoblastic Leukemia PURIXAN is indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62484-0020

What is NDC 62484-0020?: 62484-0020 is the product NDC for Purixan, Mercaptopurine 20 mg/mL suspension, listed with the FDA by Nova Laboratories, Ltd. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Purixan.
What is the active ingredient?: Mercaptopurine.
Who is the labeler?: Nova Laboratories, Ltd, NDC labeler code 62484. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Purixan?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 205919

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 205919
Product	Strength	Form · route	Labeler	Product NDC
Mercaptopurine	Mercaptopurine 20 mg/mL	SuspensionOral	Nova Laboratories, Ltd	62484-1020